The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of ...

Optimized to scale across a global network of core laboratories ... training and deployment time, allowing Roche to focus on delivering life-saving diagnostic solutions to patients.

DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Biomarkers Diagnostics ... Six players dominate the market: Roche Diagnostics, Abbott Rapid Diagnostics (formally Alere), Quidel Corporation ...

Roche has announced a new 'open innovation' research alliance in nanotechnology to develop new diagnostic tools. The Swiss company is to work with BioMed X, a new open innovation lab in Heidelberg ...

Roche Diagnostics CEO Matt Sause stated: “Gastric cancer remains a significant global health challenge ... created and published by Medical Device Network, a GlobalData owned brand.

Roche also announced ... and continue to expand our diagnostic solutions,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development.

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out ...

Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and ...

M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “Well over 55 million people worldwide are living with dementia, of which around 70% have Alzheimer's.

Roche announced that new data were ... III trontinemab programme and continue to expand our diagnostic solutions,” said Levi Garraway, M.D., Ph.D., Roche’s chief medical officer and head of global ...